FASTKD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.751600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.504000E-01
Normal-vs-Stage2
9.945200E-01
Normal-vs-Stage3
2.656200E-01
Normal-vs-Stage4
2.989800E-01
Stage1-vs-Stage2
9.358200E-01
Stage1-vs-Stage3
7.969900E-02
Stage1-vs-Stage4
1.269400E-01
Stage2-vs-Stage3
1.569230E-01
Stage2-vs-Stage4
1.187620E-01
Stage3-vs-Stage4
3.628300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.800200E-01
Normal-vs-AfricanAmerican
7.519200E-01
Normal-vs-Asian
8.563600E-01
Caucasian-vs-AfricanAmerican
5.821400E-01
Caucasian-vs-Asian
7.564000E-01
AfricanAmerican-vs-Asian
5.035600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.061600E-01
Normal-vs-Female
9.488000E-01
Male-vs-Female
5.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.563200E-01
Normal-vs-Age(41-60Yrs)
7.590800E-01
Normal-vs-Age(61-80Yrs)
8.754600E-01
Normal-vs-Age(81-100Yrs)
9.279800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.323700E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.261600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.242840E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.029990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.980400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.479000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.612000E-01
Normal-vs-Daily Drinker
6.699400E-01
Normal-vs-Weekly Drinker
8.362200E-01
Normal-vs-Occasional Drinker
4.064400E-01
Normal-vs-Social Drinker
9.709200E-01
Non Drinker-vs-Daily Drinker
8.409600E-01
Non Drinker-vs-Weekly Drinker
3.334000E-01
Non Drinker-vs-Occasional Drinker
6.463600E-03
Non Drinker-vs-Social Drinker
2.927400E-01
Daily Drinker-vs-Weekly Drinker
3.897200E-01
Daily Drinker-vs-Occasional Drinker
2.502400E-02
Daily Drinker-vs-Social Drinker
4.459000E-01
Weekly Drinker-vs-Occasional Drinker
8.312200E-01
Weekly Drinker-vs-Social Drinker
6.420600E-01
Occasional Drinker-vs-Social Drinker
1.419790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.132580E-01
Normal-vs-Grade 2
5.080400E-02
Normal-vs-Grade 3
1.419940E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.094450E-01
Grade 1-vs-Grade 3
2.841800E-02
Grade 1-vs-Grade 4
1.132580E-01
Grade 2-vs-Grade 3
4.927000E-01
Grade 2-vs-Grade 4
5.080400E-02
Grade 3-vs-Grade 4
1.419940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.337200E-01
Normal-vs-NonDiabetic
9.530800E-01
Diabetic-vs-NonDiabetic
2.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.232800E-01
Normal-vs-NoPancreatitis
9.091400E-01
Pancreatitis-vs-NoPancreatitis
6.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.749800E-01
Normal-vs-N1
9.678000E-01
N0-vs-N1
5.284000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.125600E-01
Normal-vs-TP53-NonMutant
9.467000E-01
TP53-Mutant-vs-TP53-NonMutant
9.906100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
